Last reviewed · How we verify
NCT07008313
Enhanced Recovery After Surgery Promotes the Rehabilitation of Patients With Acute Gastrointestinal Perforation in Perioperative Period
NA trial testing The enhanced recovery after surgery in Acute Gastrointestinal Perforation in 362 participants. Completed in 31 January 2023.
1 January 2023
Quick facts
| Lead sponsor | Hebei Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 362 |
| Start date | 1 October 2018 |
| Primary completion | 1 January 2023 |
| Estimated completion | 31 January 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- The enhanced recovery after surgery
- Traditional treatment methods.
Conditions studied
- Acute Gastrointestinal Perforation — all drugs for Acute Gastrointestinal Perforation →
- Enhanced Recovery After Surgery — all drugs for Enhanced Recovery After Surgery →
Sponsor
Hebei Medical University
Who can join
Adults 14 to 80, any sex, with Acute Gastrointestinal Perforation or Enhanced Recovery After Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The enhanced recovery after surgery(ERAS) has been gradually extended from its initial colorectal surgery to almost all surgical fields. However, there are few reports about the application value of ERAS in emergency surgery. The goal of this clinical trial is to evaluate the value of ERAS in the perioperative period of acute gastrointestinal perforation. All the patients will be treated by emergency operation. The changes of CRP, PA, PCT in Plasma 1 hour before operation and 1,3,7 days after operation, the operation time, the amount of bleeding during operation, the recovery time of intestinal function and the time of the first meal after operation,the incidence of postoperative complications, the degree of postoperative pain, the time of first out-of-bed activity, fatigue and mental status, quality of life, the length and the cost of hospital stay will be monitored and recorded.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07008313
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hebei Medical University trials
Trials by the same sponsor.
- NCT07304258 — A Prospective, Phase II Clinical Study of HIPEC Combined With NIPS and Tislelizumab Conversion Therapy for Gastric Cance · Phase 2 · not yet recruiting
- NCT06934824 — Clinical Study of Double-Endoscopic Combined With Minimally Invasive Treatment for Early Gastric Cancer at Clinical Stag · NA · not yet recruiting
- NCT06534814 — Development and Application of an Artificial Intelligence-driven Accurate Identification Model for Gastric Cancer Lymph · recruiting
- NCT06201585 — Exploratory Study of Single-port Robot-assisted Gastrectomy · NA · unknown
- NCT06073483 — Exploratory Study of Toumai Endoscopic Surgery System for Remote Gastrectomy · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07008313 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hebei Medical University
- Last refreshed: 6 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07008313.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing